These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35275495)

  • 1. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Roberge G; Carrier M
    Clin Appl Thromb Hemost; 2022; 28():10760296221086283. PubMed ID: 35275495
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2.
    Lindhoff-Last E; Schoenborn L; Piorkowski M; Herold J; Greinacher A; Sheppard JA; Warkentin TE
    Thromb Haemost; 2022 Feb; 122(2):304-307. PubMed ID: 34794199
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Uzun G; Pelzl L; Singh A; Bakchoul T
    Front Immunol; 2022; 13():837629. PubMed ID: 35273612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 timeline of events.
    Webster P
    Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.
    Pang X; Liu H; He X; Ji T; Zhu Y; Cui Y
    Front Immunol; 2021; 12():782335. PubMed ID: 35095856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
    Chan WY; Howells L; Wilson W; Sanchez E; Ainley L; Chavda SJ; Dowling E; Correia N; Lecat CSY; McMillan A; Wisniowski B; Mahmood S; Papanikolaou X; Lee L; Sive J; Kyriakou C; Wechalekar A; Popat R; Rabin N; Nastouli E; Yong KL; Xu K
    Br J Haematol; 2022 Feb; 196(3):e21-e26. PubMed ID: 34632575
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
    Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
    Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
    Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
    EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
    Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
    Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
    [No Abstract]   [Full Text] [Related]  

  • 12. VITT and Second Doses of Covid-19 Vaccine.
    Lacy J; Pavord S; Brown KE
    N Engl J Med; 2022 Jan; 386(1):95. PubMed ID: 34936738
    [No Abstract]   [Full Text] [Related]  

  • 13. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
    Hasegawa T; Yazaki Y
    Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
    [No Abstract]   [Full Text] [Related]  

  • 15. Papilledema due to Vaccine-Induced Thrombocytopenia.
    Qian J; Lutchman C; Margolin E
    Ophthalmology; 2022 Feb; 129(2):190. PubMed ID: 35065733
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination.
    Al-Ahmad M; Al Rasheed M; Shalaby N; Rodriguez-Bouza T; Altourah L
    Clin Appl Thromb Hemost; 2022; 28():10760296211073920. PubMed ID: 35108113
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia.
    Uzun G; Althaus K; Singh A; Möller P; Ziemann U; Mengel A; Rosenberger P; Guthoff M; Petzold GC; Müller J; Büchsel M; Feil K; Henkes H; Heyne N; Maschke M; Limpach C; Nagel S; Sachs UJ; Fend F; Bakchoul T
    Blood; 2021 Sep; 138(11):992-996. PubMed ID: 34166507
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario.
    Nasreen S; Chung H; He S; Brown KA; Gubbay JB; Buchan SA; Fell DB; Austin PC; Schwartz KL; Sundaram ME; Calzavara A; Chen B; Tadrous M; Wilson K; Wilson SE; Kwong JC;
    Nat Microbiol; 2022 Mar; 7(3):379-385. PubMed ID: 35132198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.